444 related articles for article (PubMed ID: 10706740)
21. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
[TBL] [Abstract][Full Text] [Related]
22. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool.
Gribben JG; Guinan EC; Boussiotis VA; Ke XY; Linsley L; Sieff C; Gray GS; Freeman GJ; Nadler LM
Blood; 1996 Jun; 87(11):4887-93. PubMed ID: 8639863
[TBL] [Abstract][Full Text] [Related]
23. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation.
Bosticardo M; Ariotti S; Losana G; Bernabei P; Forni G; Novelli F
Eur J Immunol; 2001 Sep; 31(9):2829-38. PubMed ID: 11536182
[TBL] [Abstract][Full Text] [Related]
24. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.
Griggs ND; Agersborg SS; Noelle RJ; Ledbetter JA; Linsley PS; Tung KS
J Exp Med; 1996 Mar; 183(3):801-10. PubMed ID: 8642284
[TBL] [Abstract][Full Text] [Related]
25. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance.
Silver PB; Hathcock KS; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(9):5041-7. PubMed ID: 11046033
[TBL] [Abstract][Full Text] [Related]
26. Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity.
Tadaki DK; Craighead N; Saini A; Celniker A; Burkly LC; Lee KP; Chute JP; Harlan DM; Kirk AD
Transplantation; 2000 Jul; 70(1):162-7. PubMed ID: 10919595
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
28. Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro.
Cai Z; Sprent J
J Exp Med; 1996 May; 183(5):2247-57. PubMed ID: 8642334
[TBL] [Abstract][Full Text] [Related]
29. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
Oberwalleney G; Henz BM; Worm M
Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
[TBL] [Abstract][Full Text] [Related]
30. B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae.
Wu ZQ; Khan AQ; Shen Y; Schartman J; Peach R; Lees A; Mond JJ; Gause WC; Snapper CM
J Immunol; 2000 Dec; 165(12):6840-8. PubMed ID: 11120807
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
32. Blocking T-cell costimulation to prevent transplant rejection.
Zheng XG; Turka LA
Transplant Proc; 1998 Aug; 30(5):2146-9. PubMed ID: 9723421
[No Abstract] [Full Text] [Related]
33. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
[TBL] [Abstract][Full Text] [Related]
34. CD28/B7 costimulation: a review.
Greenfield EA; Nguyen KA; Kuchroo VK
Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
[TBL] [Abstract][Full Text] [Related]
35. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.
Koenen HJ; Joosten I
Blood; 2000 May; 95(10):3153-61. PubMed ID: 10807782
[TBL] [Abstract][Full Text] [Related]
36. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
37. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
38. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
[TBL] [Abstract][Full Text] [Related]
39. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.
Wu Y; Guo Y; Huang A; Zheng P; Liu Y
J Exp Med; 1997 Apr; 185(7):1327-35. PubMed ID: 9104819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]